Switch theme
Sign up to access all valuation multiples
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
1990
374
LTM Revenue $605M
LTM EBITDA $130M
$297M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Kamada has a last 12-month revenue of $605M and a last 12-month EBITDA of $130M.
In the most recent fiscal year, Kamada achieved revenue of $43.6M and an EBITDA of $7.5M.
Kamada expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Kamada valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $38.6M | $43.6M | XXX | XXX | XXX |
| Gross Profit | $12.7M | $15.0M | XXX | XXX | XXX |
| Gross Margin | 33% | 34% | XXX | XXX | XXX |
| EBITDA | $6.1M | $7.5M | XXX | XXX | XXX |
| EBITDA Margin | 16% | 17% | XXX | XXX | XXX |
| Net Profit | -$0.6M | $2.2M | XXX | XXX | XXX |
| Net Margin | -2% | 5% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Kamada's stock price is ILS 23 (or $6).
Kamada has current market cap of ILS 1.3B (or $365M), and EV of ILS 1.1B (or $297M).
See Kamada trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $297M | $365M | XXX | XXX | XXX | XXX | $0.27 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Kamada has market cap of $365M and EV of $297M.
Kamada's trades at 1.8x LTM EV/Revenue multiple, and 8.4x LTM EBITDA.
Analysts estimate Kamada's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Kamada and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $297M | XXX | XXX | XXX |
| EV/Revenue | 6.8x | XXX | XXX | XXX |
| EV/EBITDA | 39.3x | XXX | XXX | XXX |
| P/E | 93.0x | XXX | XXX | XXX |
| P/E/Growth | 0.7x | XXX | XXX | XXX |
| EV/FCF | 29.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpKamada's NTM/LTM revenue growth is 12%
Kamada's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $36K for the same period.
Over next 12 months, Kamada's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Kamada's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Kamada and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 24% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 30% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $36K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 13% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 9% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 31% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Kamada acquired XXX companies to date.
Last acquisition by Kamada was XXXXXXXX, XXXXX XXXXX XXXXXX . Kamada acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Kamada founded? | Kamada was founded in 1990. |
| Where is Kamada headquartered? | Kamada is headquartered in Israel. |
| How many employees does Kamada have? | As of today, Kamada has 374 employees. |
| Who is the CEO of Kamada? | Kamada's CEO is Mr. Amir London. |
| Is Kamada publicy listed? | Yes, Kamada is a public company listed on TAE. |
| What is the stock symbol of Kamada? | Kamada trades under KMDA ticker. |
| When did Kamada go public? | Kamada went public in 2005. |
| Who are competitors of Kamada? | Similar companies to Kamada include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Kamada? | Kamada's current market cap is $365M |
| What is the current revenue of Kamada? | Kamada's last 12-month revenue is $605M. |
| What is the current EBITDA of Kamada? | Kamada's last 12-month EBITDA is $130M. |
| What is the current EV/Revenue multiple of Kamada? | Current revenue multiple of Kamada is 1.8x. |
| What is the current EV/EBITDA multiple of Kamada? | Current EBITDA multiple of Kamada is 8.4x. |
| What is the current revenue growth of Kamada? | Kamada revenue growth between 2023 and 2024 was 13%. |
| Is Kamada profitable? | Yes, Kamada is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
